References
- Hehlmann R, Hochhaus A, Baccarani M. European Leukemia Net. Chronic myeloid leukaemia. Lancet 2007; 370: 342–350
- Landgren O, Goldin L R, Kristinsson S Y, Helgadottir E A, Samuelsson J, Björkholm M. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood 2008; 112: 2199–2204
- Tokuhata G K, Neely C L, Williams D L. Chronic myelocytic leukemia in identical twins and a sibling. Blood 1968; 31: 216–225
- Gunz F W, Gunz J P, Veale A M, Chapman C J, Houston I B. Familial leukaemia, a study of 909 families. Scand J Haematol 1975; 2: 117–131
- Lillicrap D A, Sterndale H. Familial chronic myeloid leukemia. Lancet 1984; 2: 699
- Kapsali E, Tsiara S, Christou L, Panteli A, Bourantas K L. Two siblings with chronic myelogenous leukemia. J Exp Clin Cancer Res 2000; 19: 541–543
- Lessen D S, Novoselac A V, Hellman G, Tapia A, Ratner L H, Najfeld V. Chronic myelogenous leukemia occurring in two brothers diagnosed 26 years apart. Cancer Genet Cytogenet 2005; 160: 73–75
- Kralovics R, Stockton D W, Prchal J T. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood 2003; 102: 3793–3796
- Skoda R, Prchal J. Lessons from familial myeloproliferative disorders. Semin Hematol 2005; 42: 266–273
- Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang S Y, Sette A, et al. Specific human cellular immunity to bcr-abl onogene-derived peptides. Blood 1996; 87: 3587
- Posthuma E F, Falkenburg J H, Apperley J F, Gratwohl A, Roosnek E, Hertenstein B, et al. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT. Blood 1999; 93: 3863–3865
- Posthuma E FM, Falkenburg J HF, Apperley J F, Gratwohl A, Roosnek E, Hertenstein B, et al. HLA-DR4 is associated with a diminished risk of the development of CML. Leukemia 2000; 14: 859–862
- Miao K R, Pan Q Q, Xue M, Fan S, Wang X Y, Pan M, et al. HLA-A*30, DRB1*07 might imply a protective effect on CML acquisition in Chinese patients. Leuk Lymphoma 2007; 48: 2152–2156